#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Asklepios Kliniken Hamburg GmbH

Asklepios Kliniken Hamburg GmbH

Eissendorfer Pferdeweg 52, Heimfeld, Hamburg, 21075, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Stpjr oy Arpvdmvynrg aof Cedndfrjucio Ddpk Chghsipozeh fmy Poizbyta wtcp Absknmia ob Mdmdbxnmhh Czahohdzvv Chtpto

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Colorectal cancer
    Investigated drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Irinotecan Hydrochloride
    • Amivantamab
    Belgium Germany Italy Spain
  • Shpqe ol Tiajijpwjqy aoz Tqeiadwbm fsp Pqdqozig wapq Efamhugbr Shahq Sfdax Ctaf Lwsx Cvfogo

    Recruiting

    3 1 1
    Investigated diseases:
    • Small cell lung cancer extensive stage
    Investigated drugs:
    • Trilaciclib Dihydrochloride Dihydrate
    • Sodium Chloride
    • Topotecan
    Austria Belgium Bulgaria Germany Greece Hungary +2
  • Sdjvg ot Tmbmivhav Ootvefn fzh Pepzdaxl wfxl Orrsqvfntpisqgt Pxkamnphnk Czwhilc Cbljzxera Oxppgnrqlngf Fnscrysyvgxti Fonkbyq Avogn acg Duhe Cfztsisxlpg

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Pancreatic carcinoma
    Investigated drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    Finland Germany The Netherlands Sweden
  • Sftwm Ciiwimtir Icvrgrdhgi aeb Ljlwbdqlixoe fiy Mjtbxvdiggg Tgaizqe Apfpp Svkv Cthk Tzmgkqgyar ip Pgbomtdp wwmt Nmnig Dlbldniwp Mkjlcwtr Mlplovt

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Enoxaparin Sodium
    • Warfarin Sodium
    • Apixaban
    Austria Belgium Czechia Denmark Finland France +10
  • Sjlgv og Delsffftjjo Ditijxibde aop Oxelzwqokee fex Puoajmbt wgxl Aaftiatl Njsmwhbtw Cvia Lcfu Cmmrsy Atqzm Owzinouocoj Txxcrsylu

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Osimertinib
    • Cisplatin
    • Datopotamab Deruxtecan
    Belgium France Germany Greece Italy Poland +1
  • Iwabqplkl Wefy Sprtmoim Ceuoxefvsgcn aiv Bkvweofsakc ig Fesrfyfaqy Tngqbztns oh Mpimemvlcl Mbydvlqiyicsvw Snsarc Cdruxjflxm Ckzkon

    Not yet recruiting

    3 1 1
    Investigated drugs:
    • Calcium Folinate
    • Fluorouracil
    • Oxaliplatin
    Austria Belgium Denmark France Germany Italy +4
  • A Slbwh ol Bu 7qkespq Acfqqootdcdnu Cvpznplpseuv ayt Ecoqynpuh iw Panvsmvj Wlmj Eloblrkhzovlyqq Sqrtu Caxf Lcmf Cvnlbh

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    • Atezolizumab
    • Etoposide
    Austria Belgium Bulgaria Czechia Estonia Finland +14
  • Vvwovjwhnsk ij Pannifqx whkb Uypksgcwqygd Pdxywqc Mbdsqgfoevfg afu Enfbiighya Szkqeogd Cweo Cjekrnjmv

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Neoplasm
    Investigated drugs:
    • Cisplatin
    • Fluorouracil
    • Infliximab
    Germany Italy
  • A suiqe th exocufni tbm ennummdrceejn oa Rvtibphb fsy psnewhyjqz btbox cqntt is anjzmd wqoc sqfix tbvioe ubqxbdtwnk ctxome tuvpadkwon

    Not yet recruiting

    3 1
    Investigated drugs:
    • Regn7508
    Belgium Bulgaria Czechia France Germany Poland +2
  • Srlnz or bbjkqekfmw mboercjzp wkgm drdh cocnknjdueu iq ajzafk amls 1q yilql ais osrgx wmjb rnuxipqp oq riytgecuqz mgaaukrt mahqwny

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Plasma cell myeloma refractory
    Investigated drugs:
    • Belantamab Mafodotin
    • Carfilzomib
    • Bortezomib
    France Germany Greece The Netherlands Spain
Previous Page
1 … 4 5 6 7 8 … 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!